In July 2017, Intsel Chimos became the majority shareholder of Diverchim CDMO, a French leader in organic synthesis of original molecules, created in 2000 and located in Roissy-en-France, Diverchim CDMO is able to manufacture Active Ingredients in small quantities from a few grams to hundreds of kilograms and is dedicated to Pharmaceutical and Cosmetic Industries.
Diverchim CDMO, thanks to its R&D historical know-how, offers the combined services of a Contract Research Organization (CRO) and a Custom Manufacturing Organization (CMO) and is able to switch from medical chemistry to recurrent productions based on robust and validated processes.
More information on www.diverchim.com